Hide Board Information

Show Board Information

BioXcel Therapeutics Inc. BTAI

Board Mod: Add me as mod

Asst Mods:

Last Post: 08/04/2025 3:36:07 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 78

BioXcel Therapeutics Inc. (NASDAQ: BTAI) Stock Message Board

1. BTAI Company Profile

    

2. BTAI Time & Sales

    

3. BTAI Recent News

    

4. BTAI Filings

    

5. BTAI Financials

    

6. BTAI Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	$BTAI H2.58 RL1.3 :LL1.17 F6.056M up	znewcar1	08/04/2025 3:36:07 PM
7	$BTAI Hod2.4 F6.056M RL1.3	znewcar1	08/04/2025 2:19:27 PM
6	$BTAI ML2.42 RL2.6 Hod2.99	znewcar1	03/14/2024 2:07:13 PM
5	$BTAI 31% v13,4M c3.99 f29,267M Hod4.20 ML2.23	znewcar1	10/30/2023 10:23:53 PM
4	BTAI 55% v4,6M c36.97 f18M preMH@43 S@32 HOD@40	znewcar1	02/14/2020 10:16:54 PM
3	BTAI 26% v1,6M c23.85 f18M H25.04	znewcar1	02/14/2020 12:19:39 AM
2	BTAI 22% v1,9M c16.71 f18M H19.89	znewcar1	01/03/2020 4:52:25 PM
1	2018-1227 +80.91% v2,714,733 c4.36 f15,645,545	znewcar1	01/19/2019 3:02:05 PM

Recent Articles

• North Coast Brewing Company Celebrates European Beer Star Win
• Lawsuit Claims Sable Offshore Misled Investors on Oil Production
• Lockheed Martin Faces Class Action as Investors Seek Justice
• SelectQuote's Legal Challenges and Impact on Investors
• AusperBio Reaches Key Milestone in Hepatitis B Trials
• Huawei Innovations in Data Centers for AI-Powered Future
• Xplor Technologies Expands Payment Solutions with Ezypay Deal
• Canton Fair's Global Roadshow Sparks International Trade Growth
• Discover Interxsoft's Innovations at PCB West 2025 Event
• Perseus Mining's New Underground Operation at Yaouré Approved
• Celebrating Community Spirit at Halsey Fest 2025 Experience
• The Remarkable 5-Year Growth of Krystal Biotech's Stock Value
• Investigating Legal Rights of RCI Hospitality Holdings Investors
• GoPro Achieves Third Emmy Win for Outstanding 360 Technology
• Grupo Aeroportuario del Pacífico Secures New Credit Line Deal
• Investing in Linde Stocks: A Decade of Growth and Returns
• Exciting New Developments in Housing Announcement Event
• NGEx Minerals Limited Obtains Approval for Royalty Spin-Off
• P2 Gold Secures Funding Through Initial Private Placement Tranche
• IEHP's Legal Counsel Addresses Recent DOJ Lawsuit Challenges
• Jameson Irish Whiskey Reveals Exciting Plans for Football Fans
• RuggON Launches Innovative Rugged Tech for Mining Safety
• Grupo Aeroportuario del Pacífico Secures $40 Million Credit Refinance
• Innovative Venture Capitalist Champions AI Growth with Menlo Ventures
• Discovering the Value of Waste Management Stock Growth
• Wilshire Quinn Capital Funds $6.1 Million Refinance Loan
• Home Flipping Profits Decline to Record Lows – What It Means
• Investigation into Quantum Corporation Class Action Lawsuit
• Explore the Art of AI: Call for Global Artist Submissions
• Important Update for Semler Scientific Investors on Class Action
• Experience Unique Stays with Exclusive Discounts in Kauai
• Wilshire Quinn Secures $6.1M Refinance Loan for New Property
• Home Flipping Faces Declining Profit Margins Amid Rising Prices
• Investigation of RxSight: Ensuring Investor Protection
• How a $1000 Investment in AZZ Stock Transformed Over 20 Years
• Celebrating World School Milk Day: Health Benefits for Students
• Transform Your Investment: The IDEXX Laboratories Journey
• Celebrating a New Beginning: Community Home Initiative in Greenville
• Automotive Properties REIT Finalizes Major Automotive Facility Deal
• Investors Urged to Act in Unicycive Class Action Lawsuit
• DACLab Unveils Kelvin: A Groundbreaking Lower-Cost DAC System
• KinderCare Learning Faces Legal Challenges Amid Care Neglect Claims
• Sivers Semiconductors Raises SEK 95 Million Through Share Issue
• Cenovus Energy Emphasizes Value of Acquisition of MEG Energy
• Texas Instruments: An Investment Journey Worth $1000
• Prime Mining Corp Seeks Vote Approval for Strategic Arrangement
• Tesla's Autonomous Vehicles Face Serious Railroad Crossing Issues
• Lennar Corp Reports Q3 Earnings Amidst Market Challenges
• Investors Urged to Join Alto Neuroscience Class Action Today
• Altimmune Investors Urged to Act Before October Lead Plaintiff Deadline